Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Sentinel Sites Study in Infants Younger Than 12 Months Who Are Prescribed Treatment With Keppra® (Levetiracetam) Oral Solution in Usual Clinical Practice

NCT01210690 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT01210690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01210690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Sentinel Sites Study in Infants Younger Than 12 Months Who Are Prescribed Treatment With Keppra® (Levetiracetam) Oral Solution in Usual Clinical Practice
Lead sponsor
UCB Pharma
Phase
Observational
Overall status
Completed
Start date
January 31, 2011
Completion date
November 30, 2013
Enrollment
101 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy